CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
about
Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Prenatal immune activation alters the adult neural epigenome but can be partly stabilised by a n-3 polyunsaturated fatty acid diet.A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
P2860
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@en
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@nl
type
label
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@en
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@nl
prefLabel
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@en
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@nl
P2093
P2860
P356
P1433
P1476
CSF GABA is reduced in first-episode psychosis and associates to symptom severity.
@en
P2093
A Malmqvist
C M Sellgren
H Fatouros-Bergman
Karolinska Schizophrenia Project (KaSP) Consortium
P2860
P2888
P304
P356
10.1038/MP.2017.25
P407
P577
2017-03-14T00:00:00Z